Administering BMS-303141 attenuated the inflammatory cell recruitment and pro-inflammatory factor monocyte chemoattractant protein-1 (MCP-1), and TNF-α, the key inflammatory factor in obesity-associated inflammation (Figure 5J). This evidence concerns the gene CCL2 and obesity disorder.